Hostname: page-component-78c5997874-4rdpn Total loading time: 0 Render date: 2024-11-05T05:40:11.913Z Has data issue: false hasContentIssue false

A case of early multiple system atrophy unveiled by antidepressant administration

Published online by Cambridge University Press:  24 June 2014

Shwu-Hua Lee
Affiliation:
Department of Psychiatry, Chang Gung Memorial Hospital, Taoyuan County, Taiwan, ROC College of Medicine, Chang Gung University, Taoyuan County, Taiwan, ROC
Chin-Song Lu
Affiliation:
College of Medicine, Chang Gung University, Taoyuan County, Taiwan, ROC Department of Neurology, Chang Gung Memorial Hospital, Taoyuan County, Taiwan, ROC
Tien-Wen Lee*
Affiliation:
Department of Psychiatry, Chang Gung Memorial Hospital, Taoyuan County, Taiwan, ROC College of Medicine, Chang Gung University, Taoyuan County, Taiwan, ROC
*
Dr Tien-Wen Lee Department of Psychiatry, Chang Gung Memorial Hospital, No. 5, Fusing St., Gueishan Township, Taoyuan County 333, Taiwan, ROC. Tel: +886 3 281200 ext. 3824; Fax: +886 3 3280267; E-mail: [email protected]

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Comment & Critique
Copyright
Copyright © Cambridge University Press 2011

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Hamilton, M.A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:5662.CrossRefGoogle ScholarPubMed
2.Hamilton, M.The assessment of anxiety states by rating. Br J Med Psychol 1959;32:5055.CrossRefGoogle ScholarPubMed
3.Pehek, EA, Nocjar, C, Roth, BL, Byrd, TA, Mabrouk, OS.Evidence for the preferential involvement of 5-HT2A serotonin receptors in stress- and drug-induced dopamine release in the rat medial prefrontal cortex. Neuropsychopharmacology 2006;31:265277.CrossRefGoogle ScholarPubMed
4.Damsa, C, Bumb, A, Bianchi-Demicheli, F et al. “Dopamine-dependent” side effects of selective serotonin reuptake inhibitors: a clinical review. J Clin Psychiatry 2004;65:10641068.CrossRefGoogle ScholarPubMed
5.Clausius, N, Born, C, Grunze, H.The relevance of dopamine agonists in the treatment of depression. Neuropsychiatry 2009;23:1525.Google ScholarPubMed
6.Vajda, FJ, Solinas, C.Current approaches to management of depression in Parkinson's disease. J Clin Neurosci 2005;12:739743.CrossRefGoogle ScholarPubMed
7.Menza, M, Defronzo Dobkin, R, Marin, H et al. A controlled trial of antidepressants in patients with Parkinson disease and depression. Neurology 2009;72:886892.CrossRefGoogle Scholar
8.Devos, D, Dujardin, K, Poirot, I et al. Comparison of desipramine and citalopram treatments for depression in Parkinson's disease: a double-blind, randomized, placebo-controlled study. Mov Disord 2008;23:850857.CrossRefGoogle ScholarPubMed
9.Stahl, SM.Stahl's essential psychopharmacology, 3rd edn.New York: Cambridge University Press, 2008: 545.Google Scholar